Amentoflavone, a biflavonoid from Biophytum sensitivum augments lymphocyte proliferation, natural killer cell and antibody dependent cellular cytotoxicity through enhanced production of IL-2 and IFN-γ and restrains serum sialic acid and gamma glutamyl transpeptidase production in tumor - Bearing animals

Journal of Experimental Therapeutics and Oncology

Volumn 6, Issue 4, 2007, Pages 285-295

  Guruvayoorappan, Chandrasekharan ^a   Kuttan, Girija ^a  

^a AMALA CANCER RESEARCH CENTRE   (India)

Author keywords

Amentoflavone; Cell mediated immunity; Cytokines; Lymphocyte proliferation; NK cell

Indexed keywords

AMENTOFLAVONE; GAMMA GLUTAMYLTRANSFERASE; GAMMA INTERFERON; INTERLEUKIN 2; MITOGENIC AGENT; SIALIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY; ARTICLE; ASCITES TUMOR CELL; BIOPHYTUM SENSITIVUM; BONE MARROW CELL; CANCER; CANCER MODEL; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOLYSIS; DRUG EFFECT; DRUG EFFICACY; DRUG ISOLATION; DRUG STRUCTURE; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; HERB; IMMUNOMODULATION; LYMPHOCYTE PROLIFERATION; MALE; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL; THYMOCYTE; TUMOR CELL DESTRUCTION; TUMOR IMMUNITY;

ANIMALS; ANTIBODY-DEPENDENT CELL CYTOTOXICITY; BIFLAVONOIDS; CARCINOMA, EHRLICH TUMOR; GAMMA-GLUTAMYLTRANSFERASE; INTERFERON TYPE II; INTERLEUKIN-2; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; MALE; MICE; MICE, INBRED BALB C; N-ACETYLNEURAMINIC ACID;

EID: 36148956700     PISSN: 13594117     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Nathanson SD. Insights into the mechanisms of lymph node metastasis. Cancer 98: 413-423, 2003.
2. Whiteside TL, Herberman RB. The role of natural killer cells in immune surveillance of cancer. Curr Opin Immunol 7: 704-710, 1995.
3. Mellstedt H. Monoclonal antibodies in human cancer. Drugs Today 39 (Suppl.): C1-C16, 2003.
4. Handel-Fernandez ME, Cheng X, Herbert LM, Lopez DM. Down-regulation of IL-12, not a shift from a T helper-1 to a T helper-2 phenotype, is responsible for impaired IFN-γ production in mammary tumor-bearing mice. J Immunol 158: 280, 1997.
5. 2 enhanced peripheral blood lymphocyte IL-10 transcription and protein production. J Immunol 157:5512, 1995.
6. Perussia B. The cytokine profile of resting and activated NK cells. Methods 9: 370-378, 1996.
7. Tsavaris N, Kosmas C, Vadiaka M, Kanelopoulos P, Boulamatsis D. Immune changes in patients with advanced breast cancer undergoing chemotherapy with taxanes. Br J Cancer 87: 21-27, 2002.
8. Vickers A. Botanical medicines for the treatment of cancer: rationale, overview of current data, and methodological considerations for phase I and II trials. Cancer Invest 20: 1069-1079, 2002.
9. Wollschlaeger BA. Herbal medicine. N Engl J Med 348: 1498-1501, 2003.
10. Thejass P and Kuttan G. Augmentation of Natural killer cell and antibody dependent cellular cytotoxicity in Balb/c mice by sulforaphane, a naturally occurring isothiocynate from broccoli through enhanced production of cytokines IL-2 and IFN-γ. Immunopharmacol Immunotoxicol 28: 443-457, 2007.
11. Ramnath V, Kuttan G and Kuttan R. Effect of Abrin on Cell-Mediated Immune Responses in Mice. Immunopharmacol Immunotoxicol 28: 1-10, 2006.
12. Puri D. The insulinotropic activity of a Nepalese medicinal plant Biophytum sensitivum: Preliminary experimental study. J Ethnopharmacol 78: 89-93, 2001.
13. Jachak SM, Bucar F, Kartnig J. Antiinflammatory activity of extracts of Biophytum sensitivum in carrageenan induced paw edema. Phytotherapy Res 13: 73-74, 1994.
14. Guruvayoorappan C and Kuttan G. Anti-angiogenic effect of Biophytum sensitivum is exerted through its cytokine modulation activity and inhibitory activity against VEGF mRNA expression, endothelial cell migration and capillary tube formation. J Exp Ther Oncol 6: 241-250, 2007.
15. Guruvayoorappan C and Kuttan G. Antioxidant potential of Biophytum sensitivum extract in vitro and in vivo. J Basic Clin Physiol Pharmacol 17(4): 255-267, 2006.
16. Lin YM, Flavin MT, Schure R, Chen FC, Sidewell R, et al. Antiviral activities of biflavonoids. Planta Med 65: 120-125, 1999.
17. Ma SC, But PP, Ooi VE, He YH, Lee SH, et al. Antiviral amentoflavone from Selaginella sinensis. Biol Pharm Bull 24: 311-312, 2001.
18. Kim HK, Son KH, Chang HW, Kang SS, Kim HP. Amentoflavone, a plant biflavone: a new potential antiinflammatory agent. Arch Pharm Res 21: 406-410, 1998.
19. Baureithel KH, Buter KB, Engesser A, Burkard W, Schaffner W. Inhibition of benzodiazepine binding in vitro by amentoflavone, a constituent of various species of Hypericum. Pharm Acta Helv 72: 153-157, 1997.
20. 4-induced microsomal lipid peroxidation. Experientia 72: 153-157, 1991.
21. Da Silva KL, Dos Santos AR, Mattos PE, Yunus RA, Delle-Monache F, Cechinel-Filho V. Chemical composition and analgesic activity of Calophyllum brasiliense leaves. Therapie 56: 431-434, 2001.
22. Ruiz de Morales J, Velez D, Subiza JL. Ehrlich tumor stimulates extramedullar hematopoiesis in mice without secreting identifiable colony-stimulating factors and without engagement of host T cells. Exp Hematol 27: 1757-1767, 1999.
23. Bucar F, Jackak SM, Noreen Y, Kartnig T, Perera P, Bohlin L, Schubert-Zsilavecz M. Amentoflavone from Biophytum sensitivum and its effect on Cox-1/Cox-2 catalysed prostaglandin biosynthesis. Planta Med 64: 373-374, 1998.
24. Kim YB, Huh ND, Koren HS, Amos DB. Natural killer (NK) and antibody dependent cellular cytotoxicity (ADCC) in specific pathogen-free (SPF) miniature swine and germ free piglets: comparison of NK and ADCC. J Immunol 125: 755-762, 1980.
25. Skoza L, Mohos S, Stable thiobarbituric acid chromophore with dimethyl sulphoxide. Application to sialic acid assay in analytical deacylation. J Biochem 159: 457-462, 1976.
26. Szasz G. Reaction rate method for gamma glutamyl transpeptidase in serum. Clin Chem 22: 2031-2055, 1976.
27. Steven A, Rosenberg D, Logo L, Lotze MT, In: Devia Jr. VT, Hellman S, Rosenberg SA, ed. Principles and Application of Biologic Therapy pp 301-302, 1985.
28. Yokoyama WM, Plougastel BFM. Immune functions encoded by the natural killer gene complex. Nat Rev 3: 304-316, 2003.
29. Ben-Eliyahu S, Shakhar G, Page GG, Stefenski V. Suppression of NK cell activity and of resistance to metastasis by stress: a role of adrenal catecholamines and β-adrenoceptors. Neuroimmunomodulation 8: 154-164, 2000.
30. Wodner-Filipowicz A, Kalberer CP. Functions of natural killer cells in immune defense against human leukemia. Swiss Med Wkly 36: 359-364, 2006.
31. th ed. New York. NY: W.H. Freeman; 2002.
32. Misawa E, Sakurai T, Yamada M, Hayasawa H, Motoyoshi K. Effects of macrophage colony-stimulating factor and interleukin-2 administration on NK. 1+ cells in mice. Int J Pharmacol 22: 967-971, 2000.
33. Khadapkar SV, Sheth NA, Bhide SV. Independence of sialic acid levels in normal and malignant growth. Cancer Res 35: 1520-1523, 1975.
34. Klopel FM, Keenan TW, Freeman FJ, et al. Glycolipid bound sialic acid levels in serum: increased levels in mice and humans bearing mammary carcinomas. Proc Nat Acad Sci USA 74: 3011-3013, 1977.
35. Schauer R, Corfield AP. Occurrence of sialic acids-chemistry, metabolism and function. In: Schauer, R, ed. Cell Biology Monographs, Vol. 10. Springer Verlag, New York, pp 5-50, 1982.
36. Leyon PV, Lini CC, Kuttan G. Inhibitory effect of Boerhaavia diffusa on experimental metastasis by B16F-10 melanoma in C57BL/6 mice. Life Sci 76, 1339-1349, 2005.
37. Holmes E, Osterander G, Hakomori S. Biosynthesis of sialylLex determinant carried by type 2 chain glycosphingolipids (IV3NeuAcIII3-FucnLc4, VI3NeuAcV3FucnLc6 and VI3NeuAcIII3V3Fuc2nLc6) in human lung carcinoma PC9 cells. J Biol Chem 261: 3737-3743, 1986.
38. West DC, Hampson IN, Arnold F, et al. Angiogenesis induced by degradation products of hyaluronic acid. Science 228: 1324-1326, 1985.
39. Obrador E, Carretero J, Ortega A, et al. Gamma glutamyl transpeptidase overexpression increases metastatic growth of B16 melanoma cells in the mouse liver. Hepatology 35, 74-81, 2002.
40. Hanigan MH. Expression of gamma-glutamyl transpeptidase provides tumor cells with a selective growth advantage at physiologic concentrations of cyst(e)ine. Carcinogenesis 16: 181-185, 1995.
41. Meister A. Selective modification of glutathione metabolism. Science 220, 472-477, 1983.